Emergen-C Settlement

If you purchased Emergen-C from June 1, 2006 to February 27, 2012 you may be eligible for a payment from a class action settlement.1

A $6.45 million settlement has been reached in a class action lawsuit challenging various statements that Alacer Corp. (“Alacer”) allegedly made in the marketing, advertising and packaging of its Emergen-C products, including immunity-related, energy-related, and metabolism-related statements. Alacer denies the allegations in the lawsuit and maintains that all statements it has made about the Emergen-C products were proper. The Court has not decided which side is right. The Court in charge of this case still has to decide whether to approve the settlement. If it does, and any appeals are resolved, benefits will be distributed to those who qualify.

You may review the Frequently Asked Questions and the Detailed Notice for more details on who is eligible for benefits under this settlement and what steps members of the Settlement Class need to take to receive benefits under this Settlement.

On April 2, 2014, the Superior Court of California County of San Francisco will hold a hearing to decide whether to give Final Approval to the settlement. Payments will be issued to Settlement Class Members with valid Claims after the Court grants “Final Approval” and after any appeals are resolved. If an appeal is lodged, resolution can take time. Please be patient.

This website will be updated periodically as the settlement progresses.

1 Capitalized terms have the same meanings as those used in the Amended Stipulation of Settlement, a copy of which may be found on this website.

Supported by:

Vadim A. Glozman
53 West Jackson Blvd. Ste 1410B
Chicago, IL 60604
(312) 757-2314